fenofibrate has been researched along with Delayed Effects, Prenatal Exposure in 5 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| " Prenatal fenofibrate administration attenuated detrimental effects induced by MIA on both the schizophrenia-like behavioral phenotype and dopamine transmission in male offspring." | 7.91 | The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. ( Aroni, S; De Felice, M; Devoto, P; Fanni, S; Frau, R; Melis, M; Muntoni, AL; Pistis, M, 2019) |
| " Valproic acid (VPA) is an anticonvulsant drug in both human and rodents with teratogenic effects during pregnancy." | 7.91 | Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats. ( Mirza, R; Sharma, B, 2019) |
| "The social motivational theory of autism spectrum disorder (ASD) focuses on social anhedonia as key causal feature of the impaired peer relationships that characterize ASD patients." | 5.56 | Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences. ( Braccagni, G; De Montis, MG; Gambarana, C; Guzzi, F; Parenti, M; Scheggi, S, 2020) |
| " Prenatal fenofibrate administration attenuated detrimental effects induced by MIA on both the schizophrenia-like behavioral phenotype and dopamine transmission in male offspring." | 3.91 | The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. ( Aroni, S; De Felice, M; Devoto, P; Fanni, S; Frau, R; Melis, M; Muntoni, AL; Pistis, M, 2019) |
| " Valproic acid (VPA) is an anticonvulsant drug in both human and rodents with teratogenic effects during pregnancy." | 3.91 | Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats. ( Mirza, R; Sharma, B, 2019) |
| "The social motivational theory of autism spectrum disorder (ASD) focuses on social anhedonia as key causal feature of the impaired peer relationships that characterize ASD patients." | 1.56 | Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences. ( Braccagni, G; De Montis, MG; Gambarana, C; Guzzi, F; Parenti, M; Scheggi, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheggi, S | 1 |
| Guzzi, F | 1 |
| Braccagni, G | 1 |
| De Montis, MG | 1 |
| Parenti, M | 1 |
| Gambarana, C | 1 |
| De Felice, M | 1 |
| Melis, M | 1 |
| Aroni, S | 1 |
| Muntoni, AL | 1 |
| Fanni, S | 1 |
| Frau, R | 1 |
| Devoto, P | 1 |
| Pistis, M | 1 |
| Mirza, R | 1 |
| Sharma, B | 1 |
| Moustafa, T | 1 |
| Fickert, P | 1 |
| Magnes, C | 1 |
| Guelly, C | 1 |
| Thueringer, A | 1 |
| Frank, S | 1 |
| Kratky, D | 1 |
| Sattler, W | 1 |
| Reicher, H | 1 |
| Sinner, F | 1 |
| Gumhold, J | 1 |
| Silbert, D | 1 |
| Fauler, G | 1 |
| Höfler, G | 1 |
| Lass, A | 1 |
| Zechner, R | 1 |
| Trauner, M | 1 |
| Staels, B | 1 |
| Vu-Dac, N | 1 |
| Kosykh, VA | 1 |
| Saladin, R | 1 |
| Fruchart, JC | 1 |
| Dallongeville, J | 1 |
| Auwerx, J | 1 |
5 other studies available for fenofibrate and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences.
Topics: Animals; Anxiety; Autistic Disorder; Behavior, Animal; Biomarkers; Disease Models, Animal; Female; F | 2020 |
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia.
Topics: Animals; Disease Models, Animal; Dopamine; Female; Fenofibrate; Male; Neuroimmunomodulation; Neurons | 2019 |
Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Topics: Animals; Anticonvulsants; Anxiety; Autism Spectrum Disorder; Autistic Disorder; Behavior, Animal; Br | 2019 |
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; | 2012 |
Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.
Topics: Acyl-CoA Oxidase; Aging; Animals; Apolipoprotein C-III; Apolipoproteins C; Base Sequence; Cells, Cul | 1995 |